Drug Interactions and Side Effects Analysis of Cyclosporine and Azathioprine and Solu-medrol and Dobutamine Hcl and Bactrim Ds and Nystatin and Pepcid and Miralax and Propofol and Imuran and Amphotericin B and Ganciclovir and Simulect and Cefuroxime and Epinephrine and Versed and Dextrose 5%
>>> Check drugs in a new way
| Report ID | Date of report | Patient age | Patient gender |
| 147003 | Jun, 27, 2006 | 37 | Male |
List of drugs the patient takes:
| Drug | Ingredient(s) |
Cyclosporine | cyclosporine |
Azathioprine | azathioprine |
Solu-medrol | methylprednisolone sodium succinate |
Dobutamine Hcl | dobutamine hydrochloride |
Bactrim Ds | sulfamethoxazole; trimethoprim |
Nystatin | nystatin |
Pepcid | famotidine |
Miralax | polyethylene glycol 3350 |
Propofol | propofol |
Imuran | azathioprine |
Amphotericin B | amphotericin b |
Ganciclovir | ganciclovir |
Simulect | basiliximab |
Cefuroxime | cefuroxime sodium |
Epinephrine | epinephrine; lidocaine hydrochloride |
Versed | midazolam hydrochloride |
Dextrose 5% | amino acids; dextrose |
| Name |
Fungal Infection |
Haemoglobin Decreased |
Lung Transplant |
Pancreatic Haemorrhage |
Pancreatic Pseudocyst |
Pancreatitis |
Post Procedural Complication |
Sepsis |
Splenectomy |
Results from eHealthMe : 8 report(s)
Comparison with the patient:
| Name | Count (% of total reports) |
Fungal Infection | 8 (100.00%) |
Haemoglobin Decreased | 8 (100.00%) |
Lung Transplant | 8 (100.00%) |
Pancreatic Haemorrhage | 8 (100.00%) |
Pancreatic Pseudocyst | 8 (100.00%) |
Pancreatitis | 8 (100.00%) |
Post Procedural Complication | 8 (100.00%) |
Sepsis | 8 (100.00%) |
Splenectomy | 8 (100.00%) |
Top 3 (total: 0. Click here to see more) co-used drugs - potential interacting drugs:
Death reported: 0
| Name | Count (% of total reports) |
Post Procedural Complication | 8 (100.00%) |
Sepsis | 8 (100.00%) |
Splenectomy | 8 (100.00%) |
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Recent drug risk analysis reports:
